Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00033332 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: dexamethasone
DRUG: pamidronate disodium
DRUG: thalidomide
DRUG: zoledronic acid

Sponsor

National Cancer Institute (NCI)